Eucrates Biomedical Acquisition Cor... (EUCR)
$10.1
0.00 (0.00%)
Rating:
Recommendation:
-
| Symbol | EUCR |
|---|---|
| Price | $10.1 |
| Beta | -0.094 |
| Volume Avg. | 0.00M |
| Market Cap | 42.481M |
| Shares () | - |
| 52 Week Range | 9.803-10.1 |
| 1y Target Est | - |
| DCF Unlevered | EUCR DCF -> | |
|---|---|---|
| DCF Levered | EUCR LDCF -> | |
| ROE | -78.74% | Strong Sell |
| ROA | 3.20% | Neutral |
| Operating Margin | - | |
| Debt / Equity | -105.28% | Sell |
| P/E | 53.16 | Strong Buy |
| P/B | -28.34 | Strong Sell |
About
Download (Excel)Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.